alpha-FMH
- Generic Name
- alpha-FMH
Histamine as a Molecular Transducer of Adaptation to Exercise
Early Phase 1
Recruiting
- Conditions
- Postexercise Hypotension
- Interventions
- Behavioral: Aerobic ExerciseBehavioral: Resistance and Aerobic ExerciseDrug: Antihistamine
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- University of Oregon
- Target Recruit Count
- 80
- Registration Number
- NCT05206227
- Locations
- 🇺🇸
University of Oregon, Eugene, Oregon, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath